Eterna Therapeutics Inc.(ERNA)

11.25+0.11+0.99%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
- Ernexa Therapeutics参与虚拟投资者"What This Means"环节，重点介绍近期与美国FDA成功举行的Pre-IND会议
  美股速递 · 02-03
  Ernexa Therapeutics参与虚拟投资者"What This Means"环节，重点介绍近期与美国FDA成功举行的Pre-IND会议
- Ernexa Therapeutics宣布FDA新药临床试验前会议成功持续推动卵巢癌首个人体试验进展
  美股速递 · 01-06
  Ernexa Therapeutics宣布FDA新药临床试验前会议成功持续推动卵巢癌首个人体试验进展
- Ernexa Therapeutics在美国血液学会年会上发布卵巢癌治疗领先细胞治疗候选药物的新临床前数据
  美股速递 · 2025-12-08
  Ernexa Therapeutics在美国血液学会年会上发布卵巢癌治疗领先细胞治疗候选药物的新临床前数据
- Eterna Therapeutics Inc.盘中异动快速下挫5.15%
  市场透视 · 2025-03-10
  Eterna Therapeutics Inc.盘中异动快速下挫5.15%
- Eterna Therapeutics Inc.盘中异动股价大涨5.23%
  市场透视 · 2025-03-07
  Eterna Therapeutics Inc.盘中异动股价大涨5.23%
- Eterna Therapeutics Inc.盘中异动股价大跌6.77%
  市场透视 · 2025-03-04
  Eterna Therapeutics Inc.盘中异动股价大跌6.77%
- Eterna Therapeutics Inc.盘中异动早盘急速下跌6.88%报0.283美元
  市场透视 · 2025-03-04
  Eterna Therapeutics Inc.盘中异动早盘急速下跌6.88%报0.283美元
- Eterna Therapeutics Inc.盘中异动临近收盘股价大跌5.08%
  市场透视 · 2025-02-28
  Eterna Therapeutics Inc.盘中异动临近收盘股价大跌5.08%
- Eterna Therapeutics Inc.盘中异动早盘股价大涨12.44%
  市场透视 · 2025-02-26
  Eterna Therapeutics Inc.盘中异动早盘股价大涨12.44%
- Eterna Therapeutics Inc.盘中异动早盘股价大跌6.04%报0.283美元
  市场透视 · 2025-02-25
  Eterna Therapeutics Inc.盘中异动早盘股价大跌6.04%报0.283美元
- Eterna Therapeutics Inc.盘中异动早盘股价大跌5.34%
  市场透视 · 2025-02-24
  Eterna Therapeutics Inc.盘中异动早盘股价大跌5.34%
- Eterna Therapeutics Inc.盘中异动急速上涨7.39%
  市场透视 · 2025-02-20
  Eterna Therapeutics Inc.盘中异动急速上涨7.39%
- Eterna Therapeutics Inc.盘中异动早盘快速下挫5.05%报0.292美元
  市场透视 · 2025-02-18
  Eterna Therapeutics Inc.盘中异动早盘快速下挫5.05%报0.292美元
- Eterna Therapeutics Inc.股价飙升11.15% 市值涨128.26万美元
  市场透视 · 2025-02-14
  Eterna Therapeutics Inc.股价飙升11.15% 市值涨128.26万美元
- Eterna Therapeutics Inc.盘中异动早盘股价大涨5.07%
  市场透视 · 2025-02-13
  Eterna Therapeutics Inc.盘中异动早盘股价大涨5.07%
- Eterna Therapeutics Inc.盘中异动急速跳水7.12%报0.300美元
  市场透视 · 2025-02-11
  Eterna Therapeutics Inc.盘中异动急速跳水7.12%报0.300美元
- Eterna Therapeutics Inc.盘中异动股价大跌8.34%
  市场透视 · 2025-02-10
  Eterna Therapeutics Inc.盘中异动股价大跌8.34%
- Eterna Therapeutics Inc.盘中异动早盘股价大涨5.91%
  市场透视 · 2025-02-07
  Eterna Therapeutics Inc.盘中异动早盘股价大涨5.91%
- Eterna Therapeutics Inc.盘中异动股价大涨10.37%报0.357美元
  市场透视 · 2025-02-06
  Eterna Therapeutics Inc.盘中异动股价大涨10.37%报0.357美元
- Eterna Therapeutics Inc.盘中异动早盘股价大跌5.27%报0.340美元
  市场透视 · 2025-02-05
  Eterna Therapeutics Inc.盘中异动早盘股价大跌5.27%报0.340美元
公司概况
公司名称
Eterna Therapeutics Inc.
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.ernexatx.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Ernexa Therapeutics Inc于1984年在特拉华州注册成立。Ernexa是一家晚期临床阶段的生物制药公司，专注于治疗癌症患者的基于IL-2细胞因子的疗法。Ernexa致力于开发IRX-2，一种基于细胞因子的新型疗法，用于治疗癌症患者。IRX-2活性成分，即IL-2和其他关键细胞因子，被假定为信号、增强和恢复被肿瘤抑制的免疫功能，从而使免疫系统能够攻击癌细胞。
- 05-20
  超过5%披露
  Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
  Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
- 05-15
  超过5%披露
  Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
  Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
- 05-15
  超过5%披露
  Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
  Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
- 05-14
  超过5%披露
  Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
  Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
- 05-14
  超过5%披露
  Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
  Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
- 05-13
  超过5%披露
  Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
  Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
- 05-11
  季度报告
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 05-04
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 03-27
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 03-20
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 03-13
  年度报告
  Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
  Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
- 02-26
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 02-11
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 02-05
  [修订]招股说明书
  Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
  Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
- 02-04
  [修订]招股说明书
  Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
  Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

分时
5日
日
周
月

数据加载中...

最高

11.51

今开

11.01

量比

0.92

最低

10.70

昨收

11.14

换手率

5.81%

Eterna Therapeutics Inc.(ERNA)

公司概况

热议股票